CritiTech is a privately held company located in Lawrence, Kansas. The Company’s primary mission is to develop drugs with superior efficacy in more difficult-to-treat cancers and immunological diseases without the side effects of current treatments.

CritiTech Inc. is built on the following fundamentals:

• Enable better medicines for challenging diseases
• Secure investor support and involvement
• Focus resources on commercialization of our technology
• Maintain and attract highly motivated individuals who can contribute
   significantly to the Company’s goals
• Build shareholder value

Investment and partnership opportunities are welcome.
For more information contact:investors@crititech.com or partners@crititech.com